PEPG Stock Analysis: Buy, Sell, or Hold?
PEPG - PepGen Inc. Common Stock
$1.75
0.11 (6.71%)
▲
5d:
+13.64%
30d:
+0.57%
90d:
-65.89%
BUY
HIGH Confidence
Analysis Updated: May 1, 2026 12:00 AM ET
Earnings: May 14, 2026
11d
Smart Money Accumulation
PEPG is down 4.8% this week, but smart money is accumulating calls. Top strike: $2 2026-06-18 with 10 OI. Call ratio: 77% View Scanner →
Strength: 5.1/10
Get Alerted When PEPG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PEPG shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PEPG shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PEPG is currently trading at $1.75, which is considered fair relative to its 30-day fair value range of $1.07 to $3.51.
Technical Outlook: Technically, PEPG is in a strong downtrend. The price is approaching resistance at $1.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: PEPG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.29 (+487.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PEPG is in a strong downtrend. The price is approaching resistance at $1.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: PEPG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.29 (+487.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.07 -
$3.51
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.7%)
- BULLISH: Trading 487.8% below Wall St target ($10.29)
Trading Range Analysis
30-Day Trading Range
$1.07 -
$3.51
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.52
Resistance Level
$1.80
Current Trend
Strong Downtrend
Technical data as of
May 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.50
Wall Street Target
$10.29
(+487.8%)
Share & Embed Analysis
Last updated: May 02, 2026 3:23 PM ET
Data refreshes hourly during market hours. Next update: 4:22 PM
Data refreshes hourly during market hours. Next update: 4:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PEPG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 58 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 60 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 63 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
